杆菌在胰腺管腺癌中持续存在,尽管进行了根除疗法
Muhammad Shahid Mehmood1, Naseeb Danaf2
1Institute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Annals of medicine and surgery (2012)
|January 7, 2026
概括
在超过40%的胰腺癌组织中发现了Helicobacter pylori (H. pylori) DNA,即使在根除后也是如此. 这种持久性细菌可能是胰腺癌发展和进展的关键因素.
科学领域:
- 胃肠道学和瘤学
- 微生物学和免疫学
背景情况:
- 胰腺管腺癌 (PDAC) 的预后不佳,五年生存率低于12%.
- 最近的研究表明,Helicobacter pylori (H. pylori) 可能会在胰腺管道微环境中持续存在,即使在胃根除成功后也是如此.
研究的目的:
- 调查胰腺管道腺癌中持久性H. pylori的患病率和致病作用.
- 探索H. pylori作为一种潜在的微生物辅助因子和PDAC的治疗点.
主要方法:
- 2024年的一项多中心研究使用分子分析在PDAC组织中检测到H. pyloriDNA.
- 大基因组测序量化了H. pylori 16S rRNA的读数.
- 用小鼠模型来评估慢性H. pylori殖民对胰腺内皮质瘤的影响.
主要成果:
- 在41.6%的PDAC组织中检测到H. pyloriDNA,包括记录有根除病例的患者.
- 在PDAC组织中,H. pylori 16S rRNA读数占PDAC组织中微生物DNA总量的2.5%.
- 机制包括CagA/VacA介导的STAT3和NF-κB激活,导致炎症和基因组不稳定.
- 在老鼠模型中,慢性殖民增加了超过60%的胰腺内皮质瘤.
结论:
- 在胰腺微环境中持久的H. pylori是PDAC中的新型微生物共同因子.
- 杆菌在驱动瘤性炎症和基因组不稳定性方面的作用需要进一步研究.
- 杆菌可以作为潜在的诊断生物标志物和PDAC的治疗点.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Peptic Ulcer Disease I: Introduction
734
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
734
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
532
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
532
Peptic Ulcer Disease IV: Management
427
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
427
Chronic Pancreatitis I: Introduction
662
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
662


